| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-551
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-551
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
| filingDate |
2009-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2012-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-WO2010038689-A1 |
| titleOfInvention |
Pharmaceutical composition for oral administration |
| abstract |
3-hydroxy-N 1- (4-methoxybenzoyl) -N 2- [4- (4-methyl-1,4-diazepan-1-yl) benzoyl] -1,2-phenylenediamine or pharmaceutically An acceptable salt and a 2% aqueous solution with a viscosity at 20 ° C. of about 6 mPa · S or more and less than about 150 mPa · S, or a 5% aqueous solution with a viscosity at 25 ° C. of 75 mPa · S or more and 400 mPa · S or less. Disclosed is a pharmaceutical composition for oral administration comprising hydroxypropylcellulose having the same, and a method for producing the same. |
| priorityDate |
2008-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |